Results 31 to 40 of about 110,363 (266)

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial [PDF]

, 2016
Vaccination with priming and expansion of tumour reacting T cells is an important therapeutic option to be used in combination with novel checkpoint inhibitors to increase the specificity of the T cell infiltrate and the efficacy of the treatment. In
Antonilli M, BARCHIESI, GIACOMO, BELLATI, FILIPPO, BENEDETTI PANICI, PIERLUIGI, CAPONNETTO, SALVATORE, Iadarola R, NAPOLETANO, Chiara, NUTI, Marianna, PIERELLI, LUCA, RAHIMI KOSHKAKI, HASSAN, RUGHETTI, Aurelia, RUSCITO, ILARY, VISCONTI, Valeria, ZIZZARI, ILARIA GRAZIA   +13 more
core   +1 more source

Salivary gland-type mammary carcinoma arising in microglandular adenosis: A case report and clinicopathological review of the literature

Cancer Treatment and Research Communications, 2020
Introduction: Microglandular adenosis (MGA) is a rare benign proliferative lesion lacking a myoepithelial cell layer; 27% of all reported cases have progressed to invasive carcinoma.
Victoria Rico, Yukiko Shibahara, Marjorie Monteiro, Elzbieta Slodkowska, Samantha Tam, Pearl Zaki, Carlo De Angelis, Edward Chow, Katarzyna Joanna Jerzak   +8 more
doaj   +1 more source

Association Between Family History of Malignant Neoplasms and Clinicopathological Features of Breast Cancer Patients

Zhongliu Fangzhi Yanjiu, 2020
Objective To investigate the association between family history of malignant neoplasms (MN-FH) and clinicopathological characteristics of patients with breast cancer.
CAO Xinhua, HAN Lifei, LYU Jianxin, HU Haolin, ZHANG Ya'nan   +4 more
doaj   +1 more source

Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast Cancer [PDF]

Journal of Pathology and Translational Medicine, 2015
With the advance in personalized therapeutic strategies in patients with breast cancer, there is an increasing need for biomarker-guided therapy. Although the immunogenicity of breast cancer has not been strongly considered in research or practice, tumor-
Sung Gwe Ahn, Joon Jeong, SoonWon Hong, Woo Hee Jung   +3 more
doaj   +1 more source

Preclinical Analysis of JAA-F11, a Specific Anti-Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging. [PDF]

, 2018
The tumor specificity of JAA-F11, a novel monoclonal antibody specific for the Thomsen-Friedenreich cancer antigen (TF-Ag-alpha linked), has been comprehensively studied by in vitro immunohistochemical (IHC) staining of human tumor and normal tissue ...
Adams, Julia, Fisk, John C, Ghazal, Diala, Jessee, Joseph, Johnson, Holly, Karacosta, Loukia G, Koury, Steven, Ludwig, Rachel, Olson, James R, Rittenhouse-Olson, Kate, Roy, Rene, Sajjad, Munawwar, Tati, Swetha, Turner, Bradley   +13 more
core   +2 more sources

Prognostic factors in metaplastic carcinoma of the breast: A multi-institutional study [PDF]

, 2014
Background: Metaplastic breast carcinoma (MBC) is a rare type of breast cancer that has basal-like characteristics and is perceived to have poorer prognosis when compared with conventional no specific type/ductal carcinomas (ductal/NST). However, current
A Luini, A M Shaaban, A Nayak, BH Smith, BT Hennessy, C H M van Deurzen, CH van Deurzen, CM Pezzi, D Dodwell, D Purnell, D Rayson, DV Spagnolo, E A Rakha, E Downs-Kelly, EA Rakha, EA Rakha, EA Rakha, EA Rakha, EA Rakha, F Climent, G M Tse, GM Tse, GR Gibson, H Gobbi, H Lee, I O Ellis, JD Beatty, JS Reis-Filho, JS Reis-Filho, K Gwin, KH Van Hoeven, M Trojani, MP Foschini, MW Kaufman, P H Tan, PP Rosen, R Yamaguchi, S Gill, SY Bae, SY Jung, T Chan, TR Lester, WH Tseng, X Wang, Z Varga   +44 more
core   +11 more sources

CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil

Frontiers in Immunology, 2022
Triple-negative breast cancer (TNBC) is known as the most intricate and hard-to-treat subtype of breast cancer. TNBC cells do not express the well-known estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2 ...
Fatemeh Nasiri, Fatemeh Nasiri, Mehrasa Kazemi, Seyed Mohamad Javad Mirarefin, Maral Mahboubi Kancha, Milad Ahmadi Najafabadi, Faeze Salem, Setareh Dashti Shokoohi, Sahar Evazi Bakhshi, Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani   +10 more
doaj   +1 more source

Adenosquamous Variant of Metaplastic Carcinoma of Breast – An Unusual Histological Variant [PDF]

Journal of Clinical and Diagnostic Research, 2015
Metaplastic carcinoma of breast refers to a heterogeneous group of neoplasms characterized by intimate admixture of adenocarcinoma with dominant areas of spindle cell, squamous cell and/ or mesenchymal differentiation.
P.U.Swathy, P.Arunalatha, K.Chandramouleeswari, S.Mary Lily, S.Ramya   +4 more
doaj   +1 more source

Triple-Negative Breast Cancer: Emerging Biomarkers for Early Diagnosis, Prognosis, and Treatment [PDF]

Middle East Journal of Cancer
Breast cancer (BC) is a heterogeneous disease characterized by significant global mortality and incidence rates. Annually, approximately 1 million cases of BC are diagnosed worldwide, with over 170,000 classified as triple-negative.
Zahra Roshanizadeh, Mohammad Reza Haghshenas, Abbas Ghaderi   +2 more
doaj   +1 more source

Update on Poly-ADP-ribose polymerase inhibition for ovarian cancer treatment [PDF]

, 2016
Background: Despite standard treatment for epithelial ovarian cancer (EOC), that involves cytoreductive surgery followed by platinum-based chemotherapy, and initial high response rates to these, up to 80 % of patients experience relapses with a median ...
Caruso, Davide, Papa, Anselmo, Strudel, Martina, Tomao, Federica, Tomao, Silverio   +4 more
core   +2 more sources